Search

everythinglearnresearchcommunity

for

Search:↓

Intradermal testing can better detect corticosteroid allergies than patch testing.

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Fractional lasers seem effective and safe for treating hair loss, but more research is needed to find the best treatment methods.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

The 16-year-old girl with hair loss was successfully treated for alopecia areata, leading to significant hair regrowth.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Corticosteroid injections for hair loss may cause eye problems, so caution is needed.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

A new lotion with halobetasol and tazarotene successfully treats acne keloidalis nuchae.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Combining hydroxychloroquine and pimecrolimus can effectively treat hair loss from discoid lupus.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Hair care practices like using relaxers and tight braiding can lead to permanent hair loss in black women.

Acne necrotica can be effectively treated with topical cream and antibiotics.

Steroid injections improved symptoms and hair regrowth in a woman with a reaction to permanent makeup.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Regenerative therapies show promise for treating vitiligo and alopecia areata.